Western Carolina Retinal Associates

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Macular degeneration6 trials

Phase

• Phase 34 trials
• Phase 1/21 trial

Status

• Completed4 trials
• Recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• 4D Molecular Therapeutics1 trial
• Apellis Pharmaceuticals, Inc.1 trial
• Astellas Pharma Global Development, Inc.1 trial
• Regeneron Pharmaceuticals1 trial
• Shanghai Henlius Biotech1 trial
• and 1 more

Running trials

• Recruiting

  Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

  NCT05438732· VisionCare, Inc.· Source

  Contact: Amy Moore, Study Coordinator

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration1 recruiting

Closed trials

• Recruiting

  A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  NCT06541704· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Completed

  Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

  NCT05536297· Phase 3· Astellas Pharma Global Development, Inc.· Source

• Recruiting

  4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

  NCT05197270· Phase 1/2· 4D Molecular Therapeutics· Source

  Contact: 4DMT Patient Advocacy

• Completed

  A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

  NCT04740671· Phase 3· Shanghai Henlius Biotech· Source

• Completed

  An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

  NCT04770545· Phase 3· Apellis Pharmaceuticals, Inc.· Source